期刊文献+

心脏磁共振纵向弛豫时间定量在肥厚型心肌病和扩张型心肌病中的应用价值 被引量:11

Value of T1 mapping techniques in patients with hypertrophic cardiomyopathy and dilated cardiomyopathy
下载PDF
导出
摘要 采用磁共振纵向弛豫时间定量(T1 mapping)成像技术评价23例肥厚型心肌病(HCM)和18例扩张型心肌病(DCM)纤维化的价值,研究初始T1值与心功能指标的相关性。结果显示初始T1值在HCM组、DCM组及对照组分别为[(1318.4±44.7)、(1353.7±56.9)、(1267.0±24.3)ms,P<0.05],HCM患者、DCM患者左心室心肌初始T1值均与左室射血分数负相关(r=-0.488,P<0.05;r=-0.659,P<0.01)。研究表明T1mapping技术可以评价HCM及DCM心肌纤维化情况,HCM及DCM患者中左室心肌初始T1值所示心肌纤维化与心功能负相关。 To explore the value of T1 mapping techniques in the evaluation myocardial fibrosis in 23 patients with hypertrophic cardiomyopathy(HCM)and 18 patients with dilated cardiomyopathy(DCM),and to study the correlation between the native T1 value and cardiac function.The native T1 values in HCM group,DCM group and control group were statistical significance[(1318.4±44.7)ms,(1353.7±56.9)ms and(1267.0±24.3)ms,(P<0.05)];the native T1 value of the left ventricular myocardium in HCM and DCM patients was negatively correlated with the LVEF(r=-0.488,P<0.05;r=-0.659,P<0.01).The study showed that T1 mapping evaluated the myocardial fibrosis of HCM and DCM noninvasively.The myocardial fibrosis shown by the native T1 value of the left ventricular myocardium was negatively correlated with cardiac function in patients with HCM and DCM.
作者 赵韧 李小虎 王婷婷 束晶苇 胡翀 赵玲玲 俞宏林 李仁民 王玉萍 余永强 Zhao Ren;Li Xiaohu;Wang Tingting(Dept of Cardiology,The First Affiliated Hospital of Anhui Medical University,Hefei 230022;Dept of Radiology,The First Affiliated Hospital of Anhui Medical University,Hefei 230022;Dept of Heart Center,The First Affiliated Hospital of Anhui Medical University,Hefei 230022)
出处 《安徽医科大学学报》 CAS 北大核心 2021年第3期490-493,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:82071897、81970446、81600286)。
关键词 T1 mapping 心肌纤维化 扩张型心肌病 肥厚型心肌病 T1 mapping myocardial fibrosis dilated cardiomyopathy hypertrophic cardiomyopathy
  • 相关文献

参考文献3

二级参考文献95

  • 1王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:60
  • 2张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 3廖玉华,袁璟.扩张型心肌病分子免疫治疗靶点的研究进展[J].中华医学杂志,2006,86(17):1158-1160. 被引量:8
  • 4Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93(5):841-842.
  • 5Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation,2006,113(14):1807-1816.
  • 6Elliott PM,Mckenna WJ.Natural history of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/11502&type=A&selectedTitle=4~58.
  • 7Cooper LT.Definition and classification of the cardiomyopathies.[EB/OL][2006-8-2].http://www.utdol.com.beckerproxy.wustl.edu/applica.../6085&type=A&selectedTitle=2~5.
  • 8McKenna WJ.Genetics of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/9673&type=A&selectedTitle=3~58.
  • 9Poliac LC,Barron ME,Maron BJ.Hypertrophic cardiomyopathy.Anesthesiology,2006,104(1):183-192.
  • 10Maron BJ,Seidman JG,Seidman CE.Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy.J Am Coll Cardiol,2004,44(11):2125-2132.

共引文献833

同被引文献96

引证文献11

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部